A clinical-note analysis of more than 1000 patients found rising off-label BPC-157 use for pain and healing, with outcomes unproven.
|Articles|December 14, 2011
Dr. Richard Lachiver Discusses Improved Patient-Centered Medical Home Models
Advertisement
Dr. Richard Lachiver, Corporate Medical Director, Healthways, Franklin, TN, talks about his work with the Hawaii Medical Services Association (HMSA), which includes enhancing patient-centered medical homes (PCMH) through a well-being support model.
In addition, Dr. Lachiver talks about HMSA's drive to engage all patients through the PCMH model, the need for electronic health records to increase information exchange, and the importance of lowering hospital readmissions through behavioral change and better coordination of care.
Advertisement
Related to this article
At an AJMC® Stakeholder Interchange in Los Angeles, leukemia specialists described a region where hospital formularies push menin inhibitor starts into the clinic, emergency department (ED) physicians may not recognize differentiation syndrome, and capitated insurance contracts steer some patients with acute myeloid leukemia away from academic centers.
Frailty, but not HIV serostatus, is tied to more severe lower urinary tract symptoms in adults with and at risk for HIV, a cross-sectional study finds.
Cost and access, not side effects, drive GLP-1 discontinuation, and obesity should be covered like diabetes, says Fatima Cody Stanford, MD.
At AMCP Nexus 2026, payers said evidence, differentiation, and delivery now matter as much as FDA approval.
About one quarter of patients with overactive bladder were taking their initial oral regimen at nearly 3 years, yet most reported symptom improvement.
Alternating platelet-rich plasma and intralesional corticosteroids was well tolerated in a pediatric Asian patient with severe alopecia areata.
Claims data show evidence of HIV virus in 5 of 2913 long-acting cabotegravir users and higher adherence vs oral therapy.
Advertisement
Advertisement
Trending on AJMC
1
Retatrutide Tops Semaglutide on A1C, Weight in Head-to-Head Trial
2
Biosimilar Entry Should Trigger a Fresh Look at Biologic Access
3
Telehealth Overtakes Travel in States With Total Abortion Bans
4
New Data Link Cabotegravir PrEP to Few HIV Cases, Higher Adherence
5